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Oxidative stressAbstract Background: Cell death pathway can occur under physiological or pathological condi-
tions. In vitro and in vivo studies have shown that D-galactosamine (DGA) induces hepatocyte dam-
age. Objective: The present study aims to evaluate the protective effect of prostaglandin E1 (PGE1)
on DGA-induced apoptosis, necrosis and oxidative stress in primary culture of human hepatocytes.
Methods: Normal human hepatocytes were obtained from the safety margin of liver specimens,
removed during hepatectomy operation to liver cancer patients, and isolated using the classical col-
lagenase perfusion method. After culture stabilization, PGE1 (1 lM) was added 2 h before DGA
(5 mM). Cultures were maintained for 24 h before the parameters for apoptosis, necrosis and oxi-
dative stress were measured. Apoptosis was studied by DNA-fragmentation, neutral (nSMase) and
acid (aSMase) sphingomyelinase and caspase-3 activity. Necrosis was investigated by lactate dehy-
drogenase (LDH) and transaminases (ALT & AST) enzymes. The oxidative stress was assessed by
malondialdehyde (MDA), glutathione (GSH), oxidized glutathione (GSSH), glutathione S-transfer-
ase (GST), glutathione peroxidase (GSPx), catalase (CAT), superoxide dismutase (SOD) and nitric
oxide (NO). Results: The hepatotoxin DGA induced apoptosis and enhanced all parameters related
to necrosis and intracellular oxidative stress. On the other hand, PGE1 reduced the measured values
for the parameters indicative for the DAG induced apoptosis, necrosis and oxidative stress. In addi-
tion, PGE1 proved also to prevent GSH depletion. The obtained results provided evidences for the
biochemical hepatotoxic effects of DGA (5 mM) especially through the induction of apoptosis,
326 S.S. Tawﬁk et al.necrosis and oxidative stress alterations in the cultured human hepatocytes. Conclusion: PGE1 could
be a useful protective treatment against DGA-induced hepatocyte cell death.
ª 2014 The Authors. Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/3.0/).1. Introduction
The liver is the principle organ involved in the metabolism and
detoxiﬁcation of biological toxins and medicinal agents. Such
metabolism is always associated with the disturbance of hepa-
tocyte biochemistry and generation of reactive oxygen species
(ROS).1 The oxidative stress is an important mechanism
responsible for dysfunction of liver.2 There is a wide range
of liver pathologies ranging from sub-clinical hepatitis up to
necro-inﬂammatory hepatitis, cirrhosis and carcinoma that
have been proved to be associated with the redox imbalance
and oxidative stress.3
Apoptosis and necrosis are two different types of cell death.
Necrosis is a non-controlled cellular disruption as a conse-
quence of extreme noxious irreversible conditions.4 In con-
trast, apoptosis is a genetically controlled cell death pathway
that can occur under physiological or pathological conditions.
It plays an important role in removing redundant, damaged or
infected cells and has a vital role in maintaining homeostasis of
liver tissue as well as during the pathogenesis of liver diseases.5
DGA is an amino-sugar with unique hepatotoxic properties
in mammals.6 The mechanism for DGA-induced liver injury,
although poorly understood, seems to be partly related to
the immune system.7 Its toxic effects are connected with insuf-
ﬁciency of UDP (uracil nucleotides)-sugar ‘‘UDP-glucose and
UDP-galactose’’, release of pro-inﬂammatory mediators (such
as TNF-a from Kupffer’s cells), loss of intracellular calcium
homeostasis and altering uridine-pool in hepatocytes.7,8 These
changes affect cell membranes, organelles and the synthesis of
proteins and nucleic acids. DGA, at higher dose, inhibits the
energy metabolism of hepatocytes, destroys the enzymes
involved in the transport of substrates to the mitochondria
and modiﬁes the phospholipid composition of membranes.9
DGA is commonly used in experimental model for induc-
tion of hepatocellular injury. A 5 mM dose of DGA has been
established as the dose which potentially induces apoptosis,
necrosis and alters cultured human hepatocytes functions.10,11
Prostaglandins are biologically active polyunsaturated fatty
acids derived from arachidonic acid present in most mamma-
lian tissues. They have been suggested to be involved in mem-
brane stabilization. In the liver, prostaglandins were found to
be involved in hepatocyte proliferation and vital defence pro-
cesses such as inﬂammation, tissue repair and immune
responses.12,13 PGE1 was found to be effective as delivering
drug selectively to hepatocytes.14 Several studies have been
conducted to assess the ability of PGE1 to reduce in vivo and
in vitro DGA-induced cell death in cultured rat hepatocytes.15
There were growing evidences that changes in intracellular
redox state appear to regulate critical biological responses.
ROS inﬂuence signals transduction and transcription-factors,
and play a central role in the pathophysiology burden of liver
injury in this sense. Propagation of the oxidative stress induced
intracellular reactions further shifts cell death from apoptotic
to necrotic pathways in DAG-treated rats’ hepatocytes.16The present study aimed at exploring the intracellular
biochemical alterations in cultured human hepatocytes that
are involved in the induction of apoptosis, necrosis and
oxidative stress by 5 mM of the hepatotoxin DAG. It also
aimed at assessing the possible protective effect of PGE1
against the progression of the DAG-induced damage in the
cultured human hepatocytes.
2. Materials and methods
This study was approved by the Ethics Committee of Medical
Research Institute, Alexandria University. All reagents used in
this study were supplied by Sigma–Aldrich Chemical (St.
Louis, MO, USA) unless otherwise stated.
Human hepatocytes were isolated from normal hepatic
parenchyma at the apparently free margin around lesions
obtained during hepatectomies done at the department of Sur-
gery, Medical Research Institute, Alexandria University. A
written informed consent was obtained from all participants
before surgery including consent to hepatectomies and to use
their resected specimen in this study. All patients were thor-
oughly investigated assessing the hepatic functions, abdominal
ultrasound and triphasic multidetector C.T. for abdomen and
pelvis were done. The included patients were six; three men
and three women with 40 ± 8 years old. Hepatectomies were
done in three cases of synchronous non-anatomical resection
of colorectal liver metastasis (one case with cancer sigmoid
and solitary lesion at segment IV b and the other two cases
with cancer rectum and having metastasis at segments V and
VIII) and the other cases; anatomical left lateral segmentec-
tomy was done for two patients who had hepatocellular carci-
noma (HCC) involving segments II and III and the last case
had an adenoma at segment IV b. We excluded patients with
Hepatitis-C virus, Hepatitis-B, patients with liver cirrhosis or
periportal ﬁbrosis.
A crush clamp technique17 using Kelly clamp was used for
parenchymal transection to fracture the parenchyma and
expose the vessels. Sealing of the vessels was done using mono-
polar diathermy, bipolar diathermy or harmonic scalpel (Ethi-
con EndoSurgery, Cincinnati, OH, USA) and wide caliber
vessels were secured with ties or clipping. Bleeding from hepa-
tic parenchyma was secured using monopolar diathermy and
Argon Plasma Coagulation.18
2.1. Preparation of primary hepatocytes and cell culture
The human hepatocytes were isolated (in immunology lab.) by
in situ collagenase perfusion of liver samples according to the
method described by Ferrini et al.19 Liver samples were ﬁrst
perfused with a non-recirculating washing solution I, pH 7.4
at a ﬂow of 75 ml/min in order to remove blood cells. After-
ward, they were perfused with a non-recirculating chelating
solution II, pH 7.4 at a ﬂow of 75 ml/min for 10 min then with
recirculating isolation solution III at a ﬂow of 75 ml/min. for
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(250 lm) and washed three times at 50 g for 5 min at 4 C in
culture medium (DEM:Ham-F12 and William’s E mediums
(1:1) supplemented with 26 mM NaHCO3, 15 mM HEPES,
0.2 g/l glutamine, 50 mg/l vitamin C, 0.04 mg/l dexa-metha-
sone, 2 mg/l insulin, 200 mg/l glucagon, 50 mg/l transferrin,
4 ng/l ethanolamine).
Cell viability was consistently more that 85% as determined
by trypan blue dye exclusion technique, based on impermeabil-
ity of viable cells to trypan blue. The number of viable lympho-
cytes/ml was calculated according to the following equation:
% of viable cells = (no of viable cells/total no counted) · 100.
Contamination of hepatocyte cultures with kupffer cells was
not detected morphologically, through latex bead ingestion
(3 lm). Hepatocytes (150,000 cells/cm2) were seeded in type I
collagen coated dishes (Iwaki, Gyouda, Japan) and cultured
in medium containing 5% fetal calf serum for 4 h. Afterward,
the medium was removed and replaced by fresh culture med-
ium without fetal bovine serum. The study was initiated 24 h
after seeding of the cells to allow stabilization of the culture.
After stabilization of cell culture, PGE1 (1 lM) was added
2 h before DGA (5 mM) and the cultures were maintained
for 24 h before the determined biochemical parameters were
measured. Apoptosis was studied by DNA-fragmentation,
neutral (nSMase) and acid (aSMase) sphingomyelinase and
caspase-3 activity. Necrosis was investigated by lactate
dehydrogenase (LDH) and transaminases (ALT & AST)
enzymes. The oxidative stress was assessed by malondialde-
hyde (MDA), glutathione (GSH), oxidized glutathione
(GSSH), glutathione S-transferase (GST), glutathione
peroxidase (GSPx), catalase (CAT), superoxide dismutase
(SOD) and nitric oxide (NO).
2.2. DNA fragmentation in hepatocytes
The fragmentation of DNA in hepatocytes was evaluated
using electrophoresis as described by Siendones et al.20 The
whole hepatocyte population was treated with 1 ml of lysis
buffer, pH 8.0, at 4 C for 10 min. Samples were incubated
with RNAse (50 lg/ml) at 37 C for 2 h and proteinase K
(100 lg/ml) at 48 C for 45 min. DNA was obtained by phe-
nol:chloroform:isoamyl alcohol (25:24:1) (Sigma Chemical
Co.) extraction and precipitated with cold isopropanol (1:1)
at 20 C for 12 h. DNA was recovered by centrifugation of
the sample at 10,000g at 4 C for 10 min. Thereafter, the pre-
cipitate was washed with 70% ethanol, dried, and resuspended
in Tris–EDTA buffer (10 mM Tris, 1 mM EDTA) at pH 8.0.
Samples (100 lg DNA) were analyzed on 1% agarose gel with
ethidium bromide.2.3. Caspase-3-associated activity
Hepatocytes were treated with 1 ml of lysis solution at 4 C for
10 min, transferred to eppendorf tubes, and centrifuged at
10,000g at 4 C for 5 min. Caspase-3 associated activity was
measured in samples (25 lg protein) by a ﬂuorometric
assay using the peptide-based substrate ac-N-acetyl-Asp-
Glu-Val-Asp-AFC (Ac-DEVD-AFC) (Bachem, Bubendorf,
Switzerland).212.4. Assays for sphingomyelinase activities
The measurement of neutral (nSMase) and acid (aSMase)
sphingomyelinase activities was carried out following the pro-
cedure described by Martin et al.22
2.5. Measurement of LDH-release and transaminases (ALT &
AST) activities
Lactate dehydrogenase (LDH) was measured by a colorimetric
routine laboratory method.23 Volume of cell lysate ranging
from 50 to 200 ml was incubated with 0.2 mM b-NADH and
0.4 mM pyruvic acid diluted in PBS, pH 7.4. LDH concentra-
tion in the sample was proportional to the linear decrease in
the absorbance at 334 nm. LDH concentration was calculated
using commercial standard. Alanine transaminase (ALT) and
aspartate transaminase (AST) were estimated according to
Bergmeyer and Bernt.24
2.6. Evaluation of lipid peroxidation and quantiﬁcation of
glutathione (GSH) and oxidized glutathione (GSSG) longer
The presence of malondialdehyde (MDA) in culture medium
was used as an index of lipid peroxidation in hepatocytes fol-
lowing TBARS ‘‘thio-barbituric acid reactive substances’’
assay.25 GSH, GSSH were quantiﬁed in hepatocytes following
the procedure described by Teare et al.26 Liver samples
(100 lg) were homogenized in ice-cold 0.1 M phosphate buf-
fer (pH 7.4). For GSH content, the homogenate was immedi-
ately mixed with sulfosalicylic acid, shaked well, centrifuged,
and 100 ll of the supernatant was added to 9.9 ml water and
spectrophotometric absorbance was recorded at 412 nm. For
GSSG, 200 ll supernatant was added to 3.78 ml water to
which 40 ll of 2-vinylpyridine was mixed to mask the GSH
and left at room temperature for 3 h before estimation.
2.7. Glutathione S transferase (GST) and glutathione
peroxidase (GSPx) assays
GST and GSPx activities were measured as described by Habig
et al.27 and Awasthi et al.28, respectively. GST activity was
assayed, using 1-chloro-2, 4-dinitrobenzene (CDNB) and 3,
4-dichloronitrobenzene (DCNB), by spectrophotometer at
room temperature by monitoring the change in absorbance
at 344, 270, and 344 nm.27 The activity of GSPx was assayed
in a l-ml system containing 0.1 M potassium phosphate
buffer, 0.2 mM NADPH, 1 i.u. glutathione reductase, 4 mM
GSH, 4 mM EDTA, 4 mM sodium azide, and 0.02 ml
glutathione peroxidase. The mixture was incubated at 37 C
for 10 min after which 10 ll of 10 mM t-butyl hydroperoxide
was added and the rate of reaction was measured using
spectrophotometer.28
2.8. Catalase (CAT) and superoxide dismutase (SOD)
activities
CAT was assayed colorimetrically at 620 nm as described by
Tawﬁk et al.29 SOD activities were determined according to
the methods of Pottathil et al.30
Figure 2 Effect of PGE1-treatment on caspase-3-associated
activity (absorbance/h/mg protein) due to DGA-induced injury
in cultured human hepatocytes (a signiﬁcantly different among
control group, b signiﬁcantly different among PGE1 group,
c signiﬁcantly different among DGA group).
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The release of NO was indirectly assessed by measuring the
accumulated nitrite using the Griess reaction as described by
Green et al.31 Nitrite was detected and analyzed by formation
of a red pink color upon treatment of a NO2
-containing sam-
ple with the Griess reagent.
2.10. Protein assay
Total protein concentration was determined by the Bio-Rad32
assay, using bovine serum albumin as standard. Measurements
were done on UV Spectrophotometer at 595 nm.
3. Statistical analysis
The Data were collected and entered into the personal com-
puter. Statistical analysis was conducted using the Statistical
Package for the Social Sciences (SPSS) version 20. Statistical
signiﬁcance was set at (P-value <0.05). Results are expressed
as means ± SD of duplicate experiments. Differences between
groups were assessed by one-way analysis of variance
(ANOVA) using the least signiﬁcant differences (LSD) test
as multiple comparison analysis according to Berenbaum.33
4. Results
The pathological examination of the resected specimen
revealed the same pathology expected preoperatively with free
safety margin in all cases. The histopathological reports
revealed; metastatic adenocarcinoma from colorectal cancer
in three cases, Fibrolamellar variant of HCC in two cases
and an adenoma in the last case.Figure 1 1.5% agarose gel showing the effect of PGE1-treatment
on DNA-fragmentation due to DGA-induced injury in cultured
human hepatocytes. ‘‘C’’ refers to control.The effect of DGA-treatment (5 mM) revealed a general
increase in the biochemical quantitation of the parameters
for apoptosis, in the cultured hepatocytes. DGA increased
the measured arbitrary units from apoptosis expressing DNA
fragmentation by gel electrophoresis (Fig. 1: 1232 ± 114,
1241 ± 117, 2689 ± 141a,b, and 1312 ± 141c, for control,
PEG1 treatment, DGA treatment and PEG1 treatment before
DGA addition, respectively). Caspase-3-associated activity in
cultured hepatocytes was expressed with the highest values in
cultures treated with DGA. These values were reduced nearly
by 50% when PGE1 was added before treatment with DAG
(Fig. 2).
Sphingomyelinase (nSMase and aSMase) activities denote
cellular levels of ceramide at the indicated times. They
decreased signiﬁcantly in DGA-group. PGE1-treatment
restored sphingomyelinase activities within normal range
(Fig. 3).
Levels of transaminases (ALT, AST) and LDH were used
as indicators to evaluate the attribution of PGE1 to the struc-
ture damage of the hepatocytes. In the present study, the
enzyme assays of transaminases showed that a toxic dose of
DGA signiﬁcantly raised the both levels of ALT and AST.
PGE1 could inhibit the enzyme activities effectively. TheFigure 3 Effect of PGE1-treatment on nSMase and aSMase
(cpm/lg protein/min) activities due to DGA-induced injury in
cultured human hepatocytes (a signiﬁcantly different among con-
trol group, b signiﬁcantly different among PGE1 group,
c signif-
icantly different among DGA group).
Figure 4 Effect of PGE1-treatment on LDH (mIU/L), ALT and
AST (IU/L) activities due to DGA-induced injury in cultured
human hepatocytes (a signiﬁcantly different among control group,
b signiﬁcantly different among PGE1 group,
c signiﬁcantly differ-
ent among DGA group).
Figure 5 Effect of PGE1-treatment on MDA, GSH and GSSH
(nmol/lg protein) contents due to DGA-induced injury in cultured
human hepatocytes (a signiﬁcantly different among control group,
b signiﬁcantly different among PGE1 group,
c signiﬁcantly differ-
ent among DGA group).
Figure 6 Effect of PGE1-treatment on total GST and GSPx (U/
mg protein) activities due to DGA-induced injury in cultured
human hepatocytes (a signiﬁcantly different among control group,
b signiﬁcantly different among PGE1 group,
c signiﬁcantly differ-
ent among DGA group).
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trol group (Fig. 4).
Depletion of intracellular-GSH and the increase in lipid
peroxidation as MDA accumulation and GSSH in cells
(Fig. 5) were used to assess the onset of oxidative injury
induced by DGA. PGE1 abolished GSH depletion and exhib-
ited remarkable lessening of raised MDA and GSSH (Fig. 5).
As shown in Figs. 6 and 7, a single dose of DGA induced
severe oxidative damage and the GST, GSPx, CAT andFigure 7 Effect of PGE1-treatment on CAT (a) and SOD (b) (U/
lg protein) activities due to DGA-induced injury in cultured
human hepatocytes (a signiﬁcantly different among control group,
b signiﬁcantly different among PGE1 group,
c signiﬁcantly differ-
ent among DGA group).
Figure 8 Effect of PGE1-treatment on NO concentration (lmol/
mg protein) due to DGA-induced injury in cultured human
hepatocytes (a signiﬁcantly different among control group, b sig-
niﬁcantly different among PGE1 group, c signiﬁcantly different
among DGA group).
330 S.S. Tawﬁk et al.SOD activities decreased markedly. PGE1 proved to normalize
the enzyme activities of the four indexes.
Similar results were obtained in case of the nitric oxide
(NO) concentration (Fig. 8), PGE1 restored nitric oxide deple-
tion caused by DGA hepatotoxin.
5. Discussion
ROS, products of normal metabolism, cause oxidant injury if
they accumulate in pathological amounts.34 Under normal
conditions, where the levels of ROS are tightly regulated and
play a role in normal metabolism, the body’s antioxidant
defences are able to successfully manage non-pathological
amounts of exogenous or endogenous oxidants from reactive
oxygen/nitrogen species.35 Among therapeutics for liver dis-
eases, protective drugs have attracted more and more atten-
tions, such as antioxidant prevention approaches. The
environment can be a source of excess oxidants, which can
cause both acute and chronic cellular injury.36 Moreover,
ROS were thought to be involved in several cellular mecha-
nisms including apoptosis.37
Hepatic injury induced by DGA is a suitable experimental
model of human liver failure.10 It induces an intense oxidative
stress in hepatocytes.16 The present work shows that DGA-
induces apoptosis followed by necrosis in cultured human
hepatocytes. The identiﬁcation of DNA fragmentation and
caspase-3 activity modiﬁcations induced by DGA in human
hepatocytes can help in the insight of the causal molecular
mechanisms responsible for the induction of apoptosis and
necrosis.
Apoptosis, known as programmed cell death, is a cellular
self-destruction mechanism involved in a variety of biological
events such as developmental remodeling, tissue homeostasis
and the removal of unwanted cells in most living tissues,
including the mammalian liver. Similar to other organs, it
plays a role in the pathogenesis of hepatic failure and organ
dysfunction after liver ischemia/reperfusion injury.38 Sien-
dones et al.5 found that generation of ROS with perturbation
of pro- and anti-oxidant ratio caused alteration in mitochon-
dria structure and hepatocytes membrane potential.
Activation of caspases has been demonstrated to be
involved during in vivo and in vitro hepatocytes’ apoptosis.39
Induction of apoptosis by DGA was related to a signiﬁcant
increase in caspase-3 processing and activity observed in hepa-
tocytes.5 Genetic and biochemical studies have uncovered a
functional network of cell death regulators.38 It has shown that
mammals have two distinct apoptosis signaling pathways. One
pathway is activated by ‘‘death receptors’’ (a subgroup of the
tissue nuclear factors family (TNF)). The other is initiated
by certain cytotoxic stress.4 Excessive generation of ROS and
caspase activation have been shown to be essential in cell
apoptosis.40
Mammalian sphingomyelinase (SMase) hydrolyzes the
phosphodiester bond in sphingomyelin (SM), yielding cera-
mide and phosphorylcholine. SMase is transiently activated
in response to a variety of extra cellular stimuli, which leads
to increased cellular levels of ceramide. Ceramide is a mem-
ber of a group of lipid signaling molecules and has a speciﬁc
role in the onset of different stress responses, including cell
growth arrest, inﬂammation, and apoptosis.41 In the present
study, sphingomyelinase decreased markedly in DGA group.Garcia et al.42 have reported that GSH has a role in the reg-
ulation of nSMase so GSH depletion sensitizes hepatocytes
to the aSMase-induced apoptosis. Osawa et al.43 have con-
cluded that activation of aSMase contributed to hepatocyte
apoptosis.
MDA level is a main marker of endogenous lipid peroxi-
dation.25 Besides, successful protection of liver damage by
efﬁciently inhibiting MDA formation and decreasing ALT
and AST, PGE1 could enhance the activities of antioxidant
enzyme system of the hepatocyte cells, including LDH
(Fig. 4).
The replenishment of GSH may occur via reduction of
GSSG by glutathione reductase or by de novo synthesis of
GSH from its constituent amino acids.44 It plays a key protec-
tive role against oxidant-induced cell death.45 There was a sig-
niﬁcant GSH-depletion and GSSG-formation after liver
reperfusion injury.2 GSH exhibits a large panel of actions in
controlling apoptosis mechanisms or membrane transport.46
Usually GSSG represents only 1–10% of the total liver
GSH.47 In the present study, liver GSSG in the DGA treated
hepatocytes culture plate accounted almost 50% of total
GSH, suggesting that there was a signiﬁcant intracellular oxi-
dative stress during the DGA treatment.
SOD and GSPx are intracellular antioxidant enzymes that
protect against oxidative stress. Hepatocytes showed suscepti-
bility to oxidative injury with depletion of antioxidant
defences, exempliﬁed by decreased GSH and CAT and raised
MDA.30,48 It has been suggested that induction of GST
enzyme was a major cell protective mechanism and accompa-
nied by elevation of intracellular GSH level.13
Our results indicate that PGE1 has a positive hepatoprotec-
tive impact on the DGA induced lesion. Since antioxidant
enzymes such as SOD and GSPx are considered to be a pri-
mary defence system for oxidative damage prevention. PGE1
exerts antioxidant effect not only through its own radical scav-
enging activity but also, by boosting the host antioxidant
enzyme system. On the other hand, we found that several
indexes showed a signiﬁcant change. GST, GSPx, CAT and
SOD activities were raised signiﬁcantly on addition of PGE1
to the cultured hepatocytes.
Massive intervention into the redox state by pharmaceuti-
cal doses of exogenous antioxidants should be considered with
caution due to the indeﬁnite role of free radicals in regulation
of apoptosis and cytotoxicity of injured cells.49 Our results
showed that DGA could increase ROS generation, but PGE1
could reverse such effect by lowering the level of intracellular
ROS.
It has previously shown that NO mediates apoptosis by
DGA in primary culture of rat hepatocytes and has been rec-
ognized as a critical mediator in numerous biological pro-
cesses.50 Some chemical aspects of NO molecule determine
its free radical capacity to mediate cell signaling. In addition,
it has been shown to exert a noxious effect in the initiation
and progression of cell death.51
Similar studies have evidenced that PGE1 pre-administra-
tion protects against NO-dependent cell death through a rapid
increase of inducible-NO synthase (NOS-2) expression which
protected against DGA-induced cell death.50,52 The factors
that inhibit hepatic injury may be, those intensifying the hepa-
tic antioxidants or free radical scavengers and those inducing
hepatocyte regeneration.
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PGE1 can effectively protect the hepatocytes from oxidation
induced death through scavenging intracellular oxidative
damage induced by ROS.Conﬂict of interest
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